Jump Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Jump Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.96M	Buy	+37,662	New	+$5.09M	0.05%	448
2026 Q1	–	Sell	-23,026	Closed	-$2.81M	–	2473
2025 Q4	$2.81M	Sell	23,026 -57,501	-71%	-$6.59M	0.03%	555
2025 Q3	$8.07M	Sell	80,527 -67,099	-45%	-$6.04M	0.1%	266
2025 Q2	$12.2M	Sell	147,626 -163,286	-53%	-$13M	0.13%	196
2025 Q1	$25.2M	Buy	+310,912	New	+$27.8M	0.33%	70
2024 Q4	–	Sell	-46,491	Closed	-$4.59M	–	2065
2024 Q3	$4.59M	Sell	46,491 -47,443	-51%	-$4.66M	0.09%	251
2024 Q2	$8.71M	Buy	93,934 +82,200	+701%	+$7.37M	0.17%	103
2024 Q1	$1.11M	Buy	+11,734	New	+$1.09M	0.03%	746
2023 Q4	–	Sell	-359,175	Closed	-$26.2M	–	2314
2023 Q3	$26.2M	Buy	359,175 +154,931	+76%	+$12.4M	0.97%	4
2023 Q2	$17M	Buy	204,244 +169,798	+493%	+$14.2M	0.63%	4
2023 Q1	$2.63M	Buy	+34,446	New	+$2.86M	0.11%	297
2022 Q4	–	Sell	-120,442	Closed	-$9.55M	–	2080
2022 Q3	$9.55M	Sell	120,442 -17,698	-13%	-$1.49M	0.37%	18
2022 Q2	$10.3M	Buy	138,140 +129,052	+1,420%	+$9.69M	0.44%	10
2022 Q1	$817K	Buy	+9,088	New	+$839K	0.03%	603

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Jump Financial's XBI Position: Q2 2026 in Review

Jump Financial opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 37,662 shares worth $5.96M. The stake represents 0.05% of the portfolio and ranks #448 among its holdings. This is a return to the name: Jump Financial previously reported a position in XBI as recently as Q4 2025.

Jump Financial first reported a position in XBI in Q1 2022 and has held it in 14 quarters since. The position peaked at $26.2M in Q3 2023. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Jump Financial held 37,662 shares of State Street SPDR S&P Biotech ETF worth $5.96M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Jump Financial position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.05% of Jump Financial's portfolio in Q2 2026, its #448 holding.
Jump Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 14 quarters since.
Jump Financial's State Street SPDR S&P Biotech ETF position peaked at $26.2M in Q3 2023.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.